Skip to main content
Figure 3 | Molecular Neurodegeneration

Figure 3

From: Increased amyloidogenic processing of transgenic human APP in X11-like deficient mouse brain

Figure 3

Human sAPP levels in APP23 mouse brain samples in the presence or absence of X11L. (A) Detection of total human sAPP, sAPPα and sAPPβswe along with human APP, X11L and α-tubulin in APP23 mouse brain tissue in the presence or absence of X11L. Membrane (P100 for APP) and cytoplasmic (S100 for sAPP, sAPPα, sAPPβswe, X11L and α-tubulin) fractions of brain regions composed of cerebral cortex, hippocampus and olfactory bulb from wild-type (WT), APP23 and APP23/X11L-Ko mice (5-6 months old) were analyzed for total human sAPP (sAPPα plus sAPPβswe by 10D1 antibody), human sAPPα (2B3 antibody), human sAPPβswe (6A1 antibody), human APP (10D1 antibody), X11L and α-tubulin by immunoblotting. (B) The densities of total human sAPP (left), sAPPα (middle) and sAPPβswe (right) bands were standardized to the density of α-tubulin, which was compared with the ratios for APP23 mice that were assigned a reference value of 1.0 (values represent the means ± S.E.). The data were analyzed by Student's t test (n = 10; **, p < 0.01).

Back to article page